pyrrolidonecarboxylic acid and Atherogenesis

pyrrolidonecarboxylic acid has been researched along with Atherogenesis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Barg, E; Bodetko, A; Hetman, M; Mielko, K; Młynarz, P; Placzkowska, S1
Alexander, D; Alonso, A; Boerwinkle, E; Manolio, TA; Nettleton, JA; Yu, B; Zheng, Y1

Other Studies

2 other study(ies) available for pyrrolidonecarboxylic acid and Atherogenesis

ArticleYear
Predisposition to atherosclerosis in children and adults with trisomy 21: biochemical and metabolomic studies.
    Pediatric endocrinology, diabetes, and metabolism, 2023, Volume: 29, Issue:3

    Topics: Acetates; Adolescent; Adult; Apolipoprotein A-I; Apolipoproteins B; Atherosclerosis; Cardiovascular Diseases; Child; Creatinine; Down Syndrome; Formates; Glutamine; Humans; Lysine; Proline; Pyrrolidonecarboxylic Acid; Risk Factors; Xanthines

2023
Genome-wide association study of a heart failure related metabolomic profile among African Americans in the Atherosclerosis Risk in Communities (ARIC) study.
    Genetic epidemiology, 2013, Volume: 37, Issue:8

    Topics: Acetyltransferases; Alleles; Atherosclerosis; Black or African American; Chromosomes, Human, Pair 2; Chromosomes, Human, Pair 5; Cohort Studies; Fatty Acids, Unsaturated; Female; Genetic Loci; Genetic Predisposition to Disease; Genome-Wide Association Study; Heart Failure; Humans; Incidence; Isoleucine; Leucine; Male; Metabolome; Metabolomics; Middle Aged; Polymorphism, Single Nucleotide; Pyrrolidonecarboxylic Acid; Risk Factors

2013